AOR was the first organization in the world to introduce R-lipoic acid, the superior form of this anti-aging, mitochondrial energy molecule, as a pharmaceutical-grade supplement for the life extension community. In the ensuing years, numerous companies followed our lead. But now some companies are promoting the use of R-dihydro-lipoic acid (R-DHLA) pills. These companies point out that R-dihydrolipoic acid is the more powerful antioxidant, and suggest that most of R-lipoic acid’s benefits come from being converted into R-dihydrolipoic acid in the body, and so they claim that it makes more sense to take R-dihydrolipoic acid directly, which would make it immediately useable.
After a careful review of the evidence, the team at AOR has concluded that these arguments do not hold up to scientific scrutiny. R-lipoic acid is by far the more evidence-backed supplement, and many of its key benefits – on cellular homeostasis, mitochondrial function, and perhaps aging itself – cannot be gained from substituting preformed R-dihydrolipoic acid in its place.
Read the full analysis on R-dihydro-lipoic acid (R-DHLA) here.
Please note that this is a copyrighted document. For discussion in the Forum, feel free to quote segments of the article, but please do not reproduce the original document wholesale.
To your health!
AOR